General Information
Revision date
2016-11-08
Product name
Fondaparinux Sodium (Arixtra) Injection
Product Synonyms
Arixtra (Fondaparinux Sodium Injection, USP) 2.5 mg/0.5 ml; Arixtra (Fondaparinux Sodium Injection, USP) 5
CAS No.
114870-03-0
1.2.1 Relevant identified uses
Pharmaceutical. Subcutaneous. Use only as directed. Refer to product insert for usage
supplier name
Mylan N.V
Emergency telephone
For Hazardous Materials Incident
Icons in SDS
Company Information
company name
Mylan N.V
e-mail address of the competent person responsible for the Safety Data Sheet
SDScontact@Mylan.com
Section 2
SECTION 2: Hazards identification
Classification (GHS-US) Pharmaceutical Agent – Handling of this product in its final form presents minimal occupational exposure risk. Patients/Consumers: Please refer to the product information insert or product label for appropriate consumer-specific information about this product when used according to the physician’s directions.
Classification (GHS-US)
Not classified
2.2 Label elements
GHS-US labeling: No labeling applicable
2.3 Other hazards
Not available
Ingredient(s) with unknown acute toxicity
Not available
